Vical, Inc. (NASDAQ: VICL) is moving higher on speculation it might restart its Ebola virus drug program.UPDATE - Notably, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE